In a new analysis published this week in its quarterly magazine *INZICHT*, the Association of Economists of Suriname (VES) has raised critical governance questions about public healthcare investment, following the Simons administration’s latest large-scale funding commitment to the country’s flagship Academic Hospital Paramaribo (AZP). The government recently announced it would allocate more than 635 million Surinamese dollars (approximately $12 million) to the hospital, earmarked for major renovation works including the Thoracic & Cardio Coronary Care Unit, the hospital’s west wing, the emergency department, the clinical chemistry and microbiology laboratory, and the hospital mortuary.
This new injection of funding comes just months after the government pledged a minimum of 60 million SRD during AZP’s 60th anniversary celebrations. That earlier commitment was dedicated to expanding operating capacity, increasing intensive care unit beds from 16 to 21, upgrading the neonatal intensive care unit, renovating emergency services, and expanding specialized nursing capacity. The latest funding continues a pattern of substantial public investment in AZP that stretches back to the previous Santokhi administration. Between 2022 and 2025, the government allocated significant budgets to renovate operating theaters, intensive care units, emergency departments and laboratories, purchase new medical equipment, and develop specialized care units including cardiology, pediatric oncology, and maternal and child care. International funding has supplemented national investment: $2.4 million for renovations and laboratory upgrades, 900,000 euros for a new cardiology unit, and 4.5 million euros for cancer radiation treatment equipment.
As the country’s primary tertiary care provider, AZP handles an enormous volume of patients: it delivers 65% of all secondary care in Suriname and 100% of the nation’s highest-complexity tertiary care. On an average day, the hospital conducts 2,000 outpatient consultations, treats more than 100 patients in the emergency department, and has more than 500 admitted inpatients. While these volume figures demonstrate the massive scope of AZP’s services, VES argues they tell the public nothing about the actual quality of care delivered — the core issue at the center of ongoing public debate.
The key gap VES identifies is a total lack of publicly available data connecting the hundreds of millions in public investment to measurable improvements in patient health outcomes. To date, there is no independent, comprehensive public evaluation that systematically links the large inflow of funding to tangible health results. Nor is there a public quality dashboard that tracks progress on standard, internationally recognized outcome indicators for each medical specialty. This creates a stark transparency asymmetry: the government and hospital are fully transparent about financial inputs — total investment amounts, renovation projects, new construction and equipment purchases — but offer no public insight into the social and health outcomes these inputs have produced.
Without systematic public reporting of health outcomes, VES argues, parliament, civil society and funding partners cannot assess whether the large-scale investments have actually delivered measurable improvements in population health. For a leading academic medical center, VES outlines a minimum set of performance indicators that should be published regularly: volume of care by medical specialty, risk-adjusted mortality rates, complication rates, hospital-acquired infection rates, 30-day hospital readmission rates, waiting times, patient-reported outcome measures (PROMs), patient-reported experience measures (PREMs), cost per treatment, and international benchmarking against peer institutions.
Since 2020, VES has consistently highlighted the need for greater transparency, efficiency and public accountability in Suriname’s healthcare sector. The association argues that for years, national health policy has overemphasized physical infrastructure and equipment investment without parallel structural reforms to healthcare organization and workforce policy. Financial injections without fundamental governance and operational reforms, VES claims, have created a vicious cycle of rising costs with insufficient improvements in care quality. To address this, VES has repeatedly called for an independent comprehensive financial audit of the entire healthcare sector, including the State Health Fund, all public and private hospitals, pharmaceutical supply chains, and other healthcare providers.
VES supports a full systemic reform centered on integrated care pathways and specialized expert centers, which create end-to-end care chains — from prevention and diagnosis through treatment, aftercare and rehabilitation — organized around specific patient conditions. This model allows for more efficient allocation of resources, improves collaboration between care providers, and makes it easier to measure and compare clinical results. The approach aligns with global value-based healthcare principles, which center health gains for patients rather than the volume of services delivered.
The core question for Suriname, VES emphasizes, is not whether AZP deserves additional public funding — it is whether successive governments have required sufficient public accountability for the social returns of these investments. To address the current transparency gap, VES proposes that all future public investments in healthcare be tied to three non-negotiable conditions: first, an independent comprehensive financial audit of the entire healthcare sector; second, a national reform program built around integrated care pathways and outcome-based funding; and third, an annual public quality and performance report that publishes internationally comparable indicators for clinical quality, patient safety, care accessibility and resource efficiency.
Only when public investments are systematically tied to transparent quality and outcome indicators will Suriname shift to a healthcare system that is driven by patient value rather than service volume, the association concludes. This shift is the essence of good governance and the foundation of lasting, sustainable reform for Suriname’s healthcare system.
